At Alvotech, we value partnerships and collaboration. Our future strategy relies heavily on our strategic selection of people and successful partnerships around the world. We believe that by working together, we can discover, develop, and deliver the best value for our customers. That will help us to set new standards in our industry and improve the quality of life of our customers.
Alvotech is open for partnerships and license agreements for its biosimilar assets worldwide. Our product pipeline includes six key monoclonal antibodies to be launched after patent expiries.
The academic collaboration connects Alvotech with people, ideas and solutions. It stimulates new thinking to support corporate growth and provides an ideal platform for learning and collaboration. We work closely with academic institutions and have developed several strategic partnerships.
We can offer you access to our expertise in research and development, manufacturing and regulatory management. By collaborating with Alvotech, you gain access to a state-of-the-art manufacturing plant and access to a high value biosimilar pipeline. Alvotech is a fast growing global biopharmaceuticals company.
Our approach to collaborations is that we aim to foster long-term business relationships. We welcome your ideas and encourage you to get to know us better. We have a history of many successful collaborations that have enabled us to grow our business and deliver value to our customers and partners around the world.
Meet us at .
Please tell us a little about yourself.